Financial Statement

Ebix, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands, except share amounts)
  September 30,
2020		 December 31,
2019
ASSETS (Unaudited)  
Current assets:    
Cash and cash equivalents $88,023 $73,228
Receivables from service providers 19,758 25,607
Short-term investments 24,522 4,443
Restricted cash 7,902 35,051
Fiduciary funds - restricted 4,757 4,966
Trade accounts receivable, less allowances of $21,908 and $21,696, respectively 132,089 153,565
Other current assets 69,917 67,074
Total current assets 346,968 363,934
     
Property and equipment, net 48,525 48,421
Right-of-use assets 13,604 19,544
Goodwill 938,680 952,404
Intangibles, net 52,864 46,955
Indefinite-lived intangibles 27,815 42,055
Capitalized software development costs, net 20,420 19,183
Deferred tax asset, net 66,992 69,227
Other assets 34,682 29,896
Total assets $1,550,550 $1,591,619
     
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Current liabilities:    
Accounts payable and accrued liabilities $68,941 $84,735
Payables to service agents 8,224 12,196
Accrued payroll and related benefits 12,079 8,755
Working capital facility 7,546 28,352
Fiduciary funds - restricted 4,757 4,966
Short-term debt 8,349 1,167
Contingent liability for accrued earn-out acquisition consideration 3,352 8,621
Current portion of long term debt and financing lease obligations, net of deferred financing costs of $920 and $575, respectively 23,620 22,091
Contract liabilities 27,807 28,712
Lease liability 4,392 5,955
Other current liabilities 29,341 29,335
Total current liabilities 198,408 234,885
     
Revolving line of credit 439,402 438,037
Long term debt and financing lease obligations, less current portion, net of deferred financing costs of $1,293 and $1,534, respectively 237,608 254,467
Contingent liability for accrued earn-out acquisition consideration — 1,474
Contract liabilities 7,474 8,541
Lease liability 9,128 13,196
Deferred tax liability, net 1,235 1,235
Other liabilities 26,725 40,339
Total liabilities 919,980 992,174
     
     
     
Stockholders’ equity:    
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at June September 30, 2020 and December 31, 2019 — —
Series Y Convertible preferred stock, $0.10 par value, 350,000 shares authorized, no shares issued and outstanding at September 30, 2020 and no shares authorized, issue and outstanding at December 31, 2019 — —
Common stock, $0.10 par value, 220,000,000 shares authorized, 30,526,793 issued and outstanding, at September 30, 2020, and 30,492,044 issued and outstanding at December 31, 2019 3,053 3,049
Additional paid-in capital 10,537 6,960
Retained earnings 683,131 618,503
Accumulated other comprehensive loss (114,295 (78,398
Total Ebix, Inc. stockholders’ equity 582,426 550,114
Noncontrolling interest 48,144 49,331
Total stockholders’ equity 630,570 599,445
Total liabilities and stockholders’ equity $1,550,550 $1,591,619
Investor Home

Investor Contacts

EBIX Inc
1 Ebix Way, Johns Creek, Georgia 30097
Ph: 678-281-2027 Fax: 678-281-2019

IR@ebix.com

David Collins, Tanya Kamatu, Chris Eddy
Catalyst Global - 212-924-9800 or ebix@catalyst-ir.com

Ebix Named in Fortune’s 2017 100 Fastest-Growing Companies

Follow us

   

Ebix Inc.
1 Ebix Way, Johns Creek,
GA 30097

Tel: +1 (678) 281-2020
Fax: +1 (678) 281-2019

  • Join Us

Copyright © 2022 Ebix Inc. Terms Of Use | Privacy Statement